Global Metaxalone Market Size, Share, Trends, COVID-19 Impact and Growth Analysis Report – Segmented By Indication, End User and Region - Industry Forecast (2024 to 2029)

Updated On: January, 2024
ID: 6666
Pages: 175

Global Metaxalone Market Size (2023 to 2028)

The Global Metaxalone Market size is expected to grow at a healthy CAGR during the forecast period.

Metaxalone is a white powder used to relax muscles and relieve pain due to strains, sprains, or musculoskeletal problems. It has a sedative and skeletal muscle relaxant effect on the body and helps relieve pain.


With an increase in the number of people who have musculoskeletal disorders such as arthritis, the metaxalone market demand is rising tremendously. An increase in the number of incidents resulting in injury, a growing number of athlete gym establishments, and a rising appeal to exercise in urban society are escalating the growth rate of the metaxalone market to an extent. Owing to a rise in the number of road accidents due to a lack of adequate facilities and the World Health Organization's and local government bodies' straitening of drug prescribing laws, metaxalone is specifically prescribed to be taken only with a doctor's prescription are opportunities for metaxalone market. Metaxalone is also used to treat older people suffering from joint, bone, and muscle problems. The growing number of older people in Europe is considered the most profitable demand for metaxalone. Furthermore, Metaxalone has benefited from expanding the pharmaceutical industry in Italy's countries, which is expected to provide multiple growth opportunities.


Side effects associated with metaxalone, such as vomiting, fatigue, fatigue, and irritability, negatively impact consumer development. In conjunction with other central nervous system depressants, Metaxalone has been shown to induce central nervous system distress in people and may cause complications for the government. These are the factors that hamper the market growth. 

COVID-19 impact on the global metaxalone market:

COVID-19 has impacted the market in a negative way overall. The countries' lockdown led to fewer vehicles on the road, and thus fewer road accidents took place. The imposition of national and regional level lockdowns has halted numerous outdoor activities, including sports and gymnasiums. It has hampered the growth of the metaxalone market. The research funds which were allotted to the development of this drug have been diverted toward the development of covid19 cure for patients. Pharmaceutical companies have reported a rise in this drug's sales as the countries have started removing lockdowns, and people are now living everyday lives.




Market Size Available

2022 to 2028

Base Year


Forecast Period

2023 to 2028

Segments Covered

By Indication, End-User, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa


This market research report on the global metaxalone market has been segmented and sub-segmented based on the indication, end-user, and region.

Metaxalone Market – By Indication:

  • Bone Pain
  • Muscle Pain            
  • Tunnel Syndrome
  • Joint Pain 
  • Others     

Based on the indication, the Bone pain segment accounts for the largest share of the metaxalone market during the forecast period. Bone pain is expected to register profitable growth during the forecast period. Increasing the case of arthritis due to an unhealthy lifestyle and more accidents will drive market growth. As more outdoor activities take place, the use of metaxalone will increase in the future. The rise in the elderly population in European countries will further drive market growth.

The Muscle pain segment is estimated to stand very next to the bone pain segment during the forecast period and is expected to register positive growth during the forecast period. The increase in population is a significant factor in positive development during the forecast period. An increase in outdoor physical activities related to fitness or daily chores will result in muscle pain, and thus the use of metaxalone will increase. The doctors raising awareness about the drug will impact market growth.

The Joint pain segment is expected to register a reasonable growth rate during the forecast period. The increase in population is a significant factor positively impacting the market growth. The prevalence of unhealthy lifestyles among people, which involves less nutrition intake, has made the joint problem more serious at young age people. It has increased the usage of metaxalone drugs. More research and development are being done in this field, and this will positively impact the market.

The Tunnel Syndrome is expected to register a healthy growth rate during the forecast period. Although tunnel syndrome gets cured, the symptoms can remain. It has led to more funds being allotted for the research and development of this drug. In the near future, we can see a lot of growth in this drug market.

Metaxalone Market – By End User:

  • Hospitals
  • Clinics
  • Others

Based on End Users, Hospitals hold a significant share of the market due to their easy accessibility and larger selling capacity. The primary reason for this is the easy accessibility of hospitals. Hospitals have a larger selling capacity than others and thus have a significant market share. Hospitals also have more credibility than others, and therefore patients prefer hospitals over other end users.

Clinics have the second-largest market share and are expected to increase in the near future. As more clinics are opened worldwide, the selling capacity will increase, and thus the growth rate will be positive in the future.

Metaxalone Market – By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, the Americas hold a significant share of the market due to market leaders' presence and the presence of a stellar healthcare system. North America has the highest market share in the world due to market leaders' presence and the presence of a high-quality healthcare system. It will increase at a reasonable rate as the population increases.

Europe is seen as the most lucrative market for metaxalone due to the increasing number of old-age populations. Furthermore, development in the pharmaceutical industry concerning Italy's countries has also facilitated numerous growth opportunities for Metaxalone.

With mounting attraction towards athletics and gymnasium, the Asia-based market has created a demand for metaxalone as a pain reliever for players. The increasing population is also a significant factor that will play a role in increasing the growth rate. Straitening medicine prescription rules by the World Health Organization and local Government bodies have opened up tremendous market opportunities for metaxalone globally.


The most promising companies leading the Global Metaxalone Market profiled in this report are Biosynth, Chunghwa Chemical Synthesis and Biotech, Sigma Aldrich, CDI Technology, Angelini, Pfizer, Aurum Pharmatech, Finetech Industry Limited, Biochem, and Oxchem Corporation.

Please wait. . . . Your request is being processed

Frequently Asked Questions

Who are the key players in the metaxalone market?

Pfizer Inc., Sandoz Inc., Aurobindo Pharma Ltd., Sun Pharmaceutical Industries Ltd., and Zydus Pharmaceuticals (USA) Inc. are some of the notable companies in the metaxalone market.

What factors are driving the growth of the metaxalone market?

The growing patient population suffering from musculoskeletal disorders and injuries, growing awareness about the benefits of muscle relaxants, and the availability of metaxalone in different formulations and dosages majorly drive the market growth.

What is the outlook for the metaxalone market in the coming years?

The metaxalone market is expected to continue to grow in the coming years due to the increasing incidence of musculoskeletal disorders and injuries, as well as the growing demand for effective and safe treatments for pain and discomfort. However, factors such as the availability of alternative treatments and increasing competition may also impact the market growth.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 1800

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us: [email protected]

Click for Request Sample